Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
IOVA
LGND
Add up to 3 more stocks
IOVA
Iovance Biotherapeutics, Inc.
-6.82%
$13.18-0.97Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$5.89B
52W Range
$1.76 - $15.30
LGND
Ligand Pharmaceuticals Incorporated
-3.45%
$296.20-10.57Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$5.94B
52W Range
$175.89 - $326.63
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 31.68 |
| Forward P/E | N/A | 31.83 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 8.00 | 6.14 |
| P/S Ratio | 18.12 | 20.43 |
| P/FCF Ratio | N/A | 45.19 |
| EV/EBITDA | N/A | 44.91 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 97.2% | 98.6% |
| Operating Margin | -153.1% | 17.6% |
| Net Margin | -89.1% | 67.9% |
| ROE | -39.3% | 20.4% |
| ROA | -31.6% | 9.0% |
| ROIC | -37.3% | 3.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.35 | 31.18 |
| Quick Ratio | 3.82 | 30.96 |
| Debt/Equity | 0.06 | 1.17 |
| Interest Coverage | N/A | 10.01 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.